Capricor Therapeutics Reports Fourth Quarter and Full Year
CAP-1002 Cell Therapy Programs -Pivotal Phase 3, HOPE-3 Trial Initiation Underway- -Entered Exclusive Partnership with Nippon Shinyaku for...
Source: globenewswire.com
Stay updated with breaking news from Additional Milestone Payments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAP-1002 Cell Therapy Programs -Pivotal Phase 3, HOPE-3 Trial Initiation Underway- -Entered Exclusive Partnership with Nippon Shinyaku for...